专利号:US-2013035307-A1 优先权日:2010-01-26 标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers 发明人:PRESTWICH GLENN D; KENNEDY THOMAS P 权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P 摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.
专利号:US-11857778-B2 优先权日:2018-01-17 标 题:Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation 发明人:HAMNER SAMUEL RICHARD; ROSS ERIKA KRISTINE; ROSENBLUTH KATHRYN H 权利人:CALA HEALTH INC 摘要:Systems and methods for treating symptoms of an inflammatory gastrointestinal disease in a patient with transcutaneous stimulation of a peripheral nerve are disclosed. The method can include any number of positioning a first peripheral nerve effector on the patient's skin to stimulate the peripheral nerve of the patient, delivering a first electrical nerve stimulation signal transcutaneously to the peripheral nerve through the first peripheral nerve effector, and modifying at least one brain or spinal cord autonomic feedback loop relating to release of neurotransmitters from the autonomic nervous system that modulate synthesis of inflammatory biomarkers and reduce inflammation relating to the inflammatory gastrointestinal disease.
专利号:WO-2023096715-A9 优先权日:2021-10-22 标 题:Immunomodulatory glycosphingolipids and methods of use thereof 发明人:KASPER DENNIS; OH SUNGWHAN 权利人:HARVARD COLLEGE 摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.
专利号:US-2022125838-A1 优先权日:2019-02-11 标题 :Immunomodulatory glycosphingolipids and methods of use thereof 发明人:OH SUNGWHAN; KASPER DENNIS L; SONG HEEBUM; PARK SEUNG BUM 权利人:HARVARD COLLEGE; SEOUL NAT UNIV R&DB FOUNDATION 摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.
专利号:US-9907753-B2 优先权日:2010-03-19 标 题 :Lipid vesicle compositions and methods of use 发明人:IRVINE DARRELL J; MOON JAEHYUN 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
专利号:CN-101627049-B 优先权日:2006-11-10 标题 :Synthesis of phthalamides
1: Niu Y, Yang P, Li H, Li Q, Lin H, Gao L, Li L. Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals. Biol Pharm Bull. 2020 Nov 1;43(11):1653-1659. doi: 10.1248/bpb.b20-00362. Epub 2020 Aug 28. 135(3):114-120. doi: 10.1016/j.jphs.2017.10.007. Epub 2017 Oct 31. 1008:1-10. doi: 10.1016/j.jchromb.2015.11.001. Epub 2015 Nov 4. 70(6):709-17. doi: 10.1007/s00228-014-1660-7. Epub 2014 Mar 11. 5: Qureshi AI, Cohen RD. Mesalamine delivery systems: do they really make much difference? Adv Drug Deliv Rev. 2005 Jan 6;57(2):281-302. doi: 10.1016/j.addr.2004.08.008. 10(10):1513-20. doi: 10.3748/wjg.v10.i10.1513.
合成参考文献
参考文献:10.1186/s12876-021-01887-2 摘要:Li S, Yin Y, Xiao D, Zou Y. Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients. BMC Gastroenterology. 2021 Aug 04;21(1):314. doi: 10.1186/s12876-021-01887-2. 摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).